Skip to main content
Top
Published in: BMC Infectious Diseases 1/2023

Open Access 01-12-2023 | Echinococcosis | Research

Collateral circulation caused by end-stage hepatic alveolar echinococcosis

Authors: Tiemin Jiang, Tuerganaili Aji, Bo Ran, Qiang Guo, Ruiqing Zhang, Ayifuhan Ahan, Abuduaini Abulizi, Talaiti Tuergan, Yingmei Shao, Hao Wen

Published in: BMC Infectious Diseases | Issue 1/2023

Login to get access

Abstract

Background

Hepatic alveolar echinococcosis (HAE), as a benign parasitic disease with malignant infiltrative activity, grows slowly in the liver, allowing sufficient time for collateral vessels to emerge in the process of vascular occlusion.

Methods

The portal vein (PV), hepatic vein and hepatic artery were observed by enhanced CT and the inferior vena cava (IVC) by angiography, respectively. Analysis of the anatomical characteristics of the collateral vessels helped to look into the pattern and characteristics of vascular collateralization caused by this specific etiology.

Results

33, 5, 12 and 1 patients were included in the formation of collateral vessels in PV, hepatic vein, IVC and hepatic artery, respectively. PV collateral vessels were divided into two categories according to different pathways: type I: portal -portal venous pathway (13 cases) and type II: type I incorporates a portal-systemic circulation pathway (20 cases). Hepatic vein (HV) collateral vessels fell into short hepatic veins. The patients with IVC collateral presented with both vertebral and lumbar venous varices. Hepatic artery collateral vessels emanating from the celiac trunk maintains blood supply to the healthy side of the liver.

Conclusions

Due to its special biological nature, HAE exhibited unique collateral vessels that were rarely seen in other diseases. An in-depth study would be of great help to improve our understanding related to the process of collateral vessel formation due to intrahepatic lesions and its comorbidity, in addition to providing new ideas for the surgical treatment of end-stage HAE.
Literature
1.
go back to reference Stojkovic M, Junghanss T. Cystic and alveolar echinococcosis. Handb Clin Neurol. 2013;114:327–34.CrossRefPubMed Stojkovic M, Junghanss T. Cystic and alveolar echinococcosis. Handb Clin Neurol. 2013;114:327–34.CrossRefPubMed
2.
go back to reference Graeter T, Ehing F, Oeztuerk S, Mason RA, Haenle MM, Kratzer W, Seufferlein T, Gruener B. Hepatobiliary complications of alveolar echinococcosis: a long-term follow-up study. World J Gastroenterol. 2015;21(16):4925–32.CrossRefPubMedPubMedCentral Graeter T, Ehing F, Oeztuerk S, Mason RA, Haenle MM, Kratzer W, Seufferlein T, Gruener B. Hepatobiliary complications of alveolar echinococcosis: a long-term follow-up study. World J Gastroenterol. 2015;21(16):4925–32.CrossRefPubMedPubMedCentral
3.
go back to reference Li S, Chen J, He Y, Deng Y, Chen J, Fang W, Zeren Z, Liu Y, Abdulaziz ATA, Yan B, et al. Clinical features, radiological characteristics, and outcomes of patients with intracranial alveolar Echinococcosis: a case series from Tibetan Areas of Sichuan Province, China. Front Neurol. 2020;11: 537565.CrossRefPubMed Li S, Chen J, He Y, Deng Y, Chen J, Fang W, Zeren Z, Liu Y, Abdulaziz ATA, Yan B, et al. Clinical features, radiological characteristics, and outcomes of patients with intracranial alveolar Echinococcosis: a case series from Tibetan Areas of Sichuan Province, China. Front Neurol. 2020;11: 537565.CrossRefPubMed
4.
go back to reference Craig PS, Giraudoux P, Wang ZH, Wang Q. Echinococcosis transmission on the Tibetan Plateau. Adv Parasitol. 2019;104:165–246.CrossRefPubMed Craig PS, Giraudoux P, Wang ZH, Wang Q. Echinococcosis transmission on the Tibetan Plateau. Adv Parasitol. 2019;104:165–246.CrossRefPubMed
5.
go back to reference Balfour GW, Stewart TG. Case of enlarged spleen complicated with ascites, both depending upon varicose dilatation and thrombosis of the portal vein. Edinb Med J. 1869;14(7):589–98.PubMedPubMedCentral Balfour GW, Stewart TG. Case of enlarged spleen complicated with ascites, both depending upon varicose dilatation and thrombosis of the portal vein. Edinb Med J. 1869;14(7):589–98.PubMedPubMedCentral
6.
go back to reference De Gaetano AM, Lafortune M, Patriquin H, De Franco A, Aubin B, Paradis K. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. AJR Am J Roentgenol. 1995;165(5):1151–5.CrossRefPubMed De Gaetano AM, Lafortune M, Patriquin H, De Franco A, Aubin B, Paradis K. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. AJR Am J Roentgenol. 1995;165(5):1151–5.CrossRefPubMed
7.
go back to reference Wei B, Huang Z, Tang C. Optimal treatment for patients with cavernous transformation of the portal vein. Front Med. 2022;9: 853138.CrossRef Wei B, Huang Z, Tang C. Optimal treatment for patients with cavernous transformation of the portal vein. Front Med. 2022;9: 853138.CrossRef
8.
go back to reference DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology (Baltimore, MD). 2009;49(5):1729–64.CrossRefPubMed DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology (Baltimore, MD). 2009;49(5):1729–64.CrossRefPubMed
9.
go back to reference Qi XS, Bai M, He CY, Yin ZX, Guo WG, Niu J, Wu FF, Han GH. Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: an 8-year retrospective single-center study. World J Gastroenterol. 2013;19(42):7447–54.CrossRefPubMedPubMedCentral Qi XS, Bai M, He CY, Yin ZX, Guo WG, Niu J, Wu FF, Han GH. Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: an 8-year retrospective single-center study. World J Gastroenterol. 2013;19(42):7447–54.CrossRefPubMedPubMedCentral
10.
go back to reference Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG clinical guideline: disorders of the hepatic and mesenteric circulation. Am J Gastroenterol. 2020;115(1):18–40.CrossRefPubMed Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG clinical guideline: disorders of the hepatic and mesenteric circulation. Am J Gastroenterol. 2020;115(1):18–40.CrossRefPubMed
11.
go back to reference Khanna R, Sarin SK. Non-cirrhotic portal hypertension—diagnosis and management. J Hepatol. 2014;60(2):421–41.CrossRefPubMed Khanna R, Sarin SK. Non-cirrhotic portal hypertension—diagnosis and management. J Hepatol. 2014;60(2):421–41.CrossRefPubMed
12.
13.
go back to reference Nardelli S, Riggio O, Gioia S, Puzzono M, Pelle G, Ridola L. Spontaneous porto-systemic shunts in liver cirrhosis: clinical and therapeutical aspects. World J Gastroenterol. 2020;26(15):1726–32.CrossRefPubMedPubMedCentral Nardelli S, Riggio O, Gioia S, Puzzono M, Pelle G, Ridola L. Spontaneous porto-systemic shunts in liver cirrhosis: clinical and therapeutical aspects. World J Gastroenterol. 2020;26(15):1726–32.CrossRefPubMedPubMedCentral
14.
go back to reference Gana JC, Serrano CA, Ling SC. Angiogenesis and portal-systemic collaterals in portal hypertension. Ann Hepatol. 2016;15(3):303–13.CrossRefPubMed Gana JC, Serrano CA, Ling SC. Angiogenesis and portal-systemic collaterals in portal hypertension. Ann Hepatol. 2016;15(3):303–13.CrossRefPubMed
15.
go back to reference Kapur S, Paik E, Rezaei A, Vu DN. Where there is blood, there is a way: unusual collateral vessels in superior and inferior vena cava obstruction. Radiographics. 2010;30(1):67–78.CrossRefPubMed Kapur S, Paik E, Rezaei A, Vu DN. Where there is blood, there is a way: unusual collateral vessels in superior and inferior vena cava obstruction. Radiographics. 2010;30(1):67–78.CrossRefPubMed
16.
go back to reference Sonin AH, Mazer MJ, Powers TA. Obstruction of the inferior vena cava: a multiple-modality demonstration of causes, manifestations, and collateral pathways. Radiographics. 1992;12(2):309–22.CrossRefPubMed Sonin AH, Mazer MJ, Powers TA. Obstruction of the inferior vena cava: a multiple-modality demonstration of causes, manifestations, and collateral pathways. Radiographics. 1992;12(2):309–22.CrossRefPubMed
17.
go back to reference Tobinick E, Vega CP. The cerebrospinal venous system: anatomy, physiology, and clinical implications. MedGenMed Medscape Gen Med. 2006;8(1):53. Tobinick E, Vega CP. The cerebrospinal venous system: anatomy, physiology, and clinical implications. MedGenMed Medscape Gen Med. 2006;8(1):53.
18.
go back to reference Nathoo N, Caris EC, Wiener JA, Mendel E. History of the vertebral venous plexus and the significant contributions of Breschet and Batson. Neurosurgery. 2011;69(5):1007–14; discussion 1014.CrossRefPubMed Nathoo N, Caris EC, Wiener JA, Mendel E. History of the vertebral venous plexus and the significant contributions of Breschet and Batson. Neurosurgery. 2011;69(5):1007–14; discussion 1014.CrossRefPubMed
20.
go back to reference Ran B, Maimaitinijiati Y, Yasen A, Jiang T, Zhang R, Guo Q, Shao Y, Wen H, Aji T. Feasibility of retrohepatic inferior vena cava resection without reconstruction for hepatic alveolar Echinococcosis. Am Surg. 2021;87(3):443–9.CrossRefPubMed Ran B, Maimaitinijiati Y, Yasen A, Jiang T, Zhang R, Guo Q, Shao Y, Wen H, Aji T. Feasibility of retrohepatic inferior vena cava resection without reconstruction for hepatic alveolar Echinococcosis. Am Surg. 2021;87(3):443–9.CrossRefPubMed
21.
go back to reference Yang X, Wang T, Kong J, Huang B, Wang W. Resection of retrohepatic inferior vena cava without reconstruction in ex vivo liver resection and autotransplantation: a retrospective study. BMC Surg. 2020;20(1):56.CrossRefPubMedPubMedCentral Yang X, Wang T, Kong J, Huang B, Wang W. Resection of retrohepatic inferior vena cava without reconstruction in ex vivo liver resection and autotransplantation: a retrospective study. BMC Surg. 2020;20(1):56.CrossRefPubMedPubMedCentral
22.
go back to reference Dulundu E, Sugawara Y, Kaneko J, Kishi Y, Akamatsu N, Matsui Y, Kokudo N, Makuuchi M. Short hepatic vein reconstruction in biliary atresia patients with absent inferior vena cava. Clin Transplant. 2007;21(1):13–7.CrossRefPubMed Dulundu E, Sugawara Y, Kaneko J, Kishi Y, Akamatsu N, Matsui Y, Kokudo N, Makuuchi M. Short hepatic vein reconstruction in biliary atresia patients with absent inferior vena cava. Clin Transplant. 2007;21(1):13–7.CrossRefPubMed
23.
go back to reference Addeo P, Bachellier P. Collateral intrahepatic circulation in presence of hepatic veins obstruction: the “half-moon.” Digest Liver Dis. 2021;53(6):789–91.CrossRef Addeo P, Bachellier P. Collateral intrahepatic circulation in presence of hepatic veins obstruction: the “half-moon.” Digest Liver Dis. 2021;53(6):789–91.CrossRef
24.
go back to reference Kamba M, Ochi S, Ochi H, Maruyama S, Sato H, Suto Y. Asymptomatic membranous obstruction of the inferior vena cava forming intrahepatic collateral pathways. J Gastroenterol. 1995;30(6):783–5.CrossRefPubMed Kamba M, Ochi S, Ochi H, Maruyama S, Sato H, Suto Y. Asymptomatic membranous obstruction of the inferior vena cava forming intrahepatic collateral pathways. J Gastroenterol. 1995;30(6):783–5.CrossRefPubMed
25.
go back to reference Salomonowitz E, Castaneda-Zuniga WR, Bass JL, Lund G, Cragg AH, Amplatz K. Transhepatic collateral pathway due to vena caval obstruction. AJR Am J Roentgenol. 1984;142(6):1210–2.CrossRefPubMed Salomonowitz E, Castaneda-Zuniga WR, Bass JL, Lund G, Cragg AH, Amplatz K. Transhepatic collateral pathway due to vena caval obstruction. AJR Am J Roentgenol. 1984;142(6):1210–2.CrossRefPubMed
Metadata
Title
Collateral circulation caused by end-stage hepatic alveolar echinococcosis
Authors
Tiemin Jiang
Tuerganaili Aji
Bo Ran
Qiang Guo
Ruiqing Zhang
Ayifuhan Ahan
Abuduaini Abulizi
Talaiti Tuergan
Yingmei Shao
Hao Wen
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Echinococcosis
Published in
BMC Infectious Diseases / Issue 1/2023
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07970-7

Other articles of this Issue 1/2023

BMC Infectious Diseases 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine